Cancer Protein Description
This report provides a detailed description of a selected cancer protein with information collected from various sources, including UniProt, the Wellcome Trust Sanger Institute’s Catalogue of Somatic Mutations in Cancer (COSMIC), and the Atlas of Genetics and Cytogenetics in Oncology and Haematology.
| Protein Name: | RERE |
| Gene Name: | RERE |
| Protein Full Name: | Arginine-glutamic acid dipeptide repeats protein |
| Alias: | ARG; arginine-glutamic acid dipeptide (RE) repeats; ARP; ATN1L; atrophin 1-like; atrophin-1-related; DNB1; KIAA0458 |
| Mass (Da): | 172424 |
| Number AA: | 1566 |
| UniProt ID: | Q9P2R6 |
| Locus ID: | 473 |
| COSMIC ID: | RERE |
| Gene location on chromosome: | 1p36.23 |
| Cancer protein type: | TSP |
| Effect of cancer mutation on protein: | UNCLEAR |
| Effect of active protein on cancer: | UNCLEAR |
| Number of cancer specimens: | 19625 |
| Percent of cancer specimens with mutations: | 1.19 |
| Deregulated in translocations: | t(1;15)(p36.2;q24) in neuroblastoma cell line |
| Normal role description: | Overexpression triggers apoptosis via BAX recruitment and caspase-3 activation. Plays a role as transcriptional repressor during development. May be involved in control of cell survival. |